| Authors: |
Runge CL; Keck School of Medicine, University of Southern California, Los Angeles, California. Electronic address: Christina.Runge@med.usc.edu., Lyness JA; NRG Oncology Statistics and Data Management Center, Philadelphia, Pennsylvania., Gillison ML; MD Anderson Cancer Center, Houston, Texas., Adelstein DJ; Cleveland Clinic Foundation, Cleveland, Ohio., Harari PM; University of Wisconsin Carbone Cancer Center, Madison, Wisconsin., Ringash J; University Health Network-Princess Margaret Hospital, Toronto, Ontario, Canada., Geiger JL; Cleveland Clinic Foundation, Cleveland, Ohio., Krempl GA; University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Blakaj DM; Ohio State University Comprehensive Cancer Center, Columbus, Ohio., Bates JE; Emory University Hospital Midtown, Atlanta, Georgia., Galloway TJ; Fox Chase Cancer Center, Philadelphia, Pennsylvania., Jones CU; Sutter Medical Center Sacramento, Roseville, California., Gensheimer MF; Stanford Cancer Institute Palo Alto, Stanford, California., Dunlap NE; The James Graham Brown Cancer Center at University of Louisville, Louisville, Kentucky., Phan J; MD Anderson Cancer Center, Houston, Texas., Caudell JJ; Moffitt Cancer Center, Tampa, Florida., Pennington JD; Southeast Clinical Oncology Research Consortium NCORP, Winston-Salem, North Carolina., Torres-Saavedra PA; Biometric Research Program, National Cancer Institute, Bethesda, Maryland (This work was performed while employed by NRG Oncology, Philadelphia, Pennsylvania)., Yom SS; UCSF Medical Center-Mount Zion, San Francisco, California., Le QT; Stanford Cancer Institute Palo Alto, Stanford, California., Movsas B; Henry Ford Cancer Institute, Detroit, Michigan. |
